SINTX TECHNOLOGIES INC (SINT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
$1.62-2.41%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · SINT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 3.9% |
| Our one-year growth estimate | diamond | -10.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 13.8 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is on a run of consecutive earnings misses and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 43 industry peers
SINT — earnings miss
Dated 2026-10-01
above, the Company intends to deliver a Call Notice to the holders of its outstanding Class B Common Stock Purchase Warrants (the “Class B Warrants”) pursuant to the terms of the Class B Warrants. The Class B Warrants provide the Company with the right to call for exercise all or a portion of the outstanding Class B Warrants upon the Company reporting Quarterly Revenue, as defined in the Class B Warrants, of at least $2.0 million for a fiscal quarter in a qualifying Revenue Evidence Filing. T…
Why it matters: Cash from exercised warrants could add up to $4.0 million. The company says those funds are not assured.
Watch forWarrant holders exercise enough of the called warrants to provide cash proceeds to SINTX.
Also watch forHolders do not exercise the called warrants by the deadline, and the warrants expire.
Why it matters: SINTX's $2.2 million Q3 figure is preliminary. The final report will show whether the large jump from Q2 holds.
Supportive ifThe Q3 report confirms revenue near $2.2 million, above the earlier $0.9 million to $1.1 million range.
Worry ifThe Q3 report cuts revenue below $2.0 million or shows a large downward change from the preliminary figure.
Why it matters: The studies may give potential partners early evidence on these products. Management said data may be ready before year-end.
Watch forSINTX starts animal studies and shares early data before year-end.
Also watch forThe studies do not start in Q3, or SINTX reports that data will not be ready before year-end.
Why it matters: Management kept its Q4 range after Q3 beat its guide. Meeting it would show that customer orders still turn into sales.
Supportive ifReported Q4 revenue is at least $1.0 million and no more than $1.3 million.
Worry ifReported Q4 revenue is below $1.0 million.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$233 on $10,000 · ±2.3% | How much price usually moves either way. |
| Bad day | $636 loss on $10,000 · 6.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,714 loss on $10,000 · 67.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.